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1. Introduction 
The alkanes, a new class of neurolipids, are accu- 
mulated in the brain myelin when compared to the 
other brain subfractions [l--4]. The role of these 
hydrophobic substances in the myelin formation is 
far from clear. It appears that alkanes are required for 
a correct myelination, since the remaining myelin of 
the Quaking mutant, which bears a defect of myelin 
formation, presents only 30%total alkanes found in 
the wild type [l]. The peripheral nervous system con- 
tains also large amounts of alkanes [S]. 
By using a microsomal fraction from rabbit sciatic 
nerve, we established that the alkanes can be synthe- 
sized by mammalians, contrary to the widely accepted 
idea that these substances are due to an exogenous 
contamination [5]. The nature of the cofactor require- 
ments and of the substrates leading to alkane synthesis 
in subcellular fractions from rabbit sciatic nerve sug- 
gested that alkanes are biosynthesized by decarboxy- 
lation of very long chain fatty acids [5]. That hypoth- 
esis would remain speculative until a synthesis of 
these acids in the peripheral nervous system has been 
demonstrated. In fact saturated very long chain fatty 
acids are well-known components of the lipids of the 
brain myelin [6-l 71, and they are assumed to play 
a great role in its stability and cohesiveness [6,7 ,I 8-221. 
Their biosynthesis has been studied in brain subfrac- 
tions [23-291. 
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Although the occurrence of very long chain fatty 
acids has been demonstrated in the peripheral nervous 
system [7,22,30 -321, their origin or the conditions 
of their formation have not been examined so far [33]. 
We report here that very long chain fatty acids can 
be synthesized in sciatic nerve and we discuss their 
probable role as precursors of myelin alkanes. 
2. Materials and methods 
The sciatic nerves were dissected immediately after 
the rabbits were sacrificed, as in [S]. They were either 
used for in vivo experiments or used for the prepara- 
tion of microsomal fractions. 
In the second case, the sciatic nerves were homoge- 
nized at 4°C with a Potter tissue grinder in 10 vol. 
0.05 M Tris-HCl, pH 7.5,0.25 M sucrose. The 
homogenate was spun at 20 000 X g for 20 min and 
the resulting supernatant was centrifuged at 150 000 Xg 
for 2 h. The pellets were resuspended in 0.05 M Tris- 
HCl, pH 7.5,0.25 M sucrose and homogenized. The 
proteins were estimated as in [34]. 
The biosynthesis of the very long chain fatty acids 
in the CZe--Cse range was measured by the incorpora- 
tion of [l -14C]acetate (5 PCi, 10 Cilmol), [ 1 -14C]- 
stearate (1 /.Ki, 1 Ci/mol) or [ l-14C]stearoyl CoA 
(0.1 @i, 1 Ci/mol). [ l-14C]Acetate was used for in 
vivo experiments. 
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With [ l-‘4C]stearate as the labelled substrate, incu- 
bation mixtures contained in final vol. 05 ml: Tris- 
HCl , pH 7 .5,50 mM, sucrose 250 mM , NADPH 0 5 Ctmol ,
malonyl-CoA 0.1 pmol, CoA 0.25 ~01, ATP 1 pmol, 
MgZ+ 1 pmol, sodium ascorbate 1 pmol, and when 
used: NADH 0.5 pm01 and /I-mercaptoethanol25 pmol. 
With [ 1 -14C]stearoyl CoA as the substrate, CoA, 
ATP and Mg* were omitted from the reaction mix- 
ture. The assays started by the addition of enzyme 
(0.3-0.6 mg protein). The incubations were carried 
out at 37°C for 1 h, stopped by the addition of 0.5 M 
KOH (0.5 ml), and saponified at 80°C for 1 h. 
The non-saponifiable matter was extracted and the 
fatty acid methyl esters were prepared as in [5,32,34-361. 
Unless otherwise stated the fatty acid methyl esters 
were subjected to thin-layer chromatography on Sili- 
cage1 G/AgNOa, 80/20 (w/w) with benzene-hexane 
70/30 (v/v) as the solvent system. The saturated fatty 
acid methyl esters were then analyzed by gas-liquid 
chromatography on an Intersmat IGC 120 DFL gas 
chromatograph equipped with a flame ionization 
detector on a l/8 in. X 6 ft column containing 10% 
SE 30 or 3% OV 17, programmed from 150-28O’C 
at 4”C/min, or on a l/8 in. X 6 ft column containing 
5% DEGS programmed from 120-220°C at 4”C/min. 
The labelled fractions were collected with a 
Packard 852 fraction collector on cartridges filled 
with anthracene. Alternatively the fatty acid methyl 
esters were analyzed with a Barber-Colman Radio- 
chromatograph 5000, equipped with the same columns 
in the same conditions. 
The radioactivity was measured by liquid scintilla- 
tion counting on a Tri carb 3003 Packard spectro- 
meter. 
3. Results and discussion 
The analysis of the lipids from rabbit sciatic nerve 
showed the presence of the CaO-Cul saturated fatty 
acids. We studied the incorporation of various labelled 
substrates, to test whether the rabbit sciatic nerve is 
able to synthesize very long chain fatty acids. 
Freshly removed sciatic nerves were allowed to 
incorporate [ 1 -14C]acetate. Figure 1 shows that the 
excised sciatic nerve is able to synthesize very long 
chain fatty acids from [l -i4C]acetate. The total fatty 
acid methyl esters including unsaturated and cw-hydroxy 
Fig.1. Total fatty acid synthesis from [ 1-“Cjacetate by excised 
rabbit sciatic nerve. The numbers refer to fatty acid chain 
length. The arrow indicates the start of the radiochromatog- 
raphy. 
fatty acids were subjected to thin-layer chromato- 
graphy. The radioactivity in saturated fatty acids was 
55% total. The label distribution within the various 
saturated fatty acids synthesized from [I-r4CC]acetate 
is given in Bg.2. Myristic, pahnitic and stearic acids 
accounted for 17%, 37% and 25% radioactivity of the 
saturated fatty acids, respectively; CZO--C& fatty 
acids were also labelled and incorporated about 18% 
total radioactivity. The label decreased from CZO 
(6.1-6.7%) to Czs (0.5-l .2%) and lignoceric acid 
accounted for about 5% total label. 
These results demonstrate for the first time the 
biosynthesis of saturated very long chain fatty acids 
by the peripheral nervous system. 
[ 1 -14C]Stearate is a good substrate for alkane syn- 
thesis by the rabbit sciatic nerve [5]. Experiments 
with excised sciatic nerves showed that [ 1 -i4C]stearate 
is elongated in C2,+& fatty acids. Subcellular frac- 
tions of the rabbit sciatic nerve were obtained and the 
elongating activity of the subfractions was tested in 
the presence of [ 1 -14C]stearate, CoA, ATP, malonyl 
CoA and NADPH, in the same experimental condi- 
tions giving rise to alkane formation [5]. The results 
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are given in table 1. AL1 the fractions incorporated 
stearate into saturated fatty acids; most of the syn- 
thesis occurred in the microsomal pellet which con- 
tained nearly 60% total elongating activity. The mea- 
sured specific activity was about 15 nmoL/mg protein/h 
from 1 ,umol stearate. Both alkanes and saturated 
very long chain fatty acids are synthesized chiefly in 
that membrane fraction. 
The analysis of the labelling of each fatty acid syn- 
thesized from [l-r4C]stearate by the various ubfrac- 
tions is given in table 2. As expected the very long 
chain fatty acids were very poorly synthesized by the 
150 000 X g supernatant ,whereas the microsomal 
pellet was, by far, the most active subfraction. The for- 
mation of C2c-&, fatty acids was observed; the label 
incorporation decreased from eicosanoic to triacon- 
tanoic acid. The formation of eicosanoic acid was 
about 7 nmol/mg protein/h, accounting for 50% of 
the label found in the saturated very long chain fatty 
acids. The synthesis of Lignoceric acid was less than 
10% total fatty acids. These results are very similar 
to those observed from in vivo experiments. 
Fig.2. Saturated fatty acid synthesisfrom [ 1-‘%Z]acetate by
excised rabbit sciatic nerve. The numbers refer to the fatty 
acid chain length. The arrow indicates the start of the radio- 
chromatography. Radioactivity was monitored with a relative 
attenuation 1 K except for C,, and C,, (3 K). 
Table 3 shows the effect of various cofactors on 
the synthesis of the saturated very long chain fatty 
acids from [ L-r4C]stearate by a microsomal pellet 
from sciatic nerve. P-Mercaptoethanol which inhibited 
completely the alkane synthesis [5] had little effect 
on the stearate longation; replacement of NADPH by 
NADH reduced the very long chain formation by 50%, 
indicating that NADPH was the preferred reducting 
agent. The omission of CoA or ATP led to a marked 
decrease of the label incorporation into saturated very 
long chain fatty acids, suggesting that stearate is not 
Table 1 
Biosynthesis of saturated very long chain fatty acids by rabbit sciatic nerve 
Homogenate 
20 000 X g pellet 
150 000 X g pellet 
150 000 X g supernatant 
Specific activity % Total 
(nmol/mg protein/h) activity 
4.9 100 
3.3 21.2 
14.9 58 
0.6 20.8 
Incorporation of [ l-Wlstearate into very long chain fatty acids. For experimental 
details see materials and methods. Results are given as nmol fatty acids synthesized/ 
mg protein/h 
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Table 2 
Saturated fatty acid synthesis from [ l-‘4C]stearate by rabbit sciatic nerve fractions 
June 1978 
Saturated fatty Homogenate 20 000 x g 150 000 x g 150 000 x g 
acid chain length pellet pellet supernatant 
20 2.5 1.5 6.9 0.26 
22 0.9 0.8 4.7 0.2 
24 0.8 0.4 1.4 0.1 
26 0.3 0.3 0.9 0.05 
28 0.3 0.2 0.7 nd. 
30 n.d. n.d. 0.2 n.d. 
The complete assay contained NADPH (0.5 lmol), ATP (1 pmol), Mg’+ (1 rmol), CoA (0.25 pmol), 
malonyl CoA (0.1 pmol), [ l-‘4C]stearate (1 PCi, 1 r&i/crmol), sodium ascorbate (1 pmol) and enzyme 
(0.5 mg). Results are given as nmol/mg protein/h. n.d., not detected 
Table 3 
Effect of various cofactors on the biosynthesis of saturated 
very long chain fatty acids by a 150 000 X g pellet of rabbit 
sciatic nerve 
Remaining 
act. (%) 
Complete assay 100 
+ /3-Mercaptoethanol 71 
+ NADH 
- NADPH 
50 
- ATP 35 
- CoA 32 
- malCoA 54 
Same experimental conditions as in table 2 (complete assay) 
and when used: NADH (0.5 crmol), pmercaptoethanol 
(25 pmol). The relative activity 100% was given to the activ- 
ity obtained with the complete assay 14.9 f 0.5 nmol/mg 
protein/h. Results are given as the remaining activity when 
cofactors were omitted, or added 
the true substrate of the microsomal elongase : proba- 
bly stearate could be activated to stearoyl CoA, and 
then elongated in the presence of malonyl CoA and 
NADPH. In order to check this hypothesis, experi- 
ments were run with [ 1 -‘4C]stearoyl CoA as the label- 
led substrate, without CoA and ATP. 
Table 4 shows that stearoyl CoA is a good substrate 
of the elongase. The main synthesis (about 60%) was 
observed in the microsomal pellet; the elongation rate 
of the stearoyl CoA was more important han that 
observed with stearate in the presence of CoA and 
ATP. From 100 nmol stearoyl CoA, about 13.3 nmol/ 
mg protein/h of saturated very long chain fatty acids 
were synthesized. The radioactivity distribution pat- 
tern within the various fatty acids was quite similar to 
that observed by using [ 1 -r4C]stearate. Eicosanoic and 
docosanoic acids contained, respectively, 53% and 22% 
total radioactivity incorporated, and lignoceric acid 
12.4%. 
Table 4 
Biosynthesis of saturated very long chain fatty acids from [ 1-“Clstearyl CoA by rabbit sciatic nerve fractions 
Saturated fatty acid synthesized homogenate 20 000 x g 150 000 x g 150 000 x g 
(chain length) pellet pellet supernatant 
20 0.84 0.74 7.07 1.42 
22 0.42 0.95 2.98 0.56 
24 0.13 0.27 1.65 0.21 
26 0.11 0.22 1.08 0.19 
28 0.10 0.02 0.52 0.32 
The complete assay contained NADPH (0.5 pmol),malonylCoA (0.1 Umol), [ 1-“Clstearyl CoA (0.1 FCi, 1 &i/Mmol), 
sodium ascorbate (1 hmol) and enzyme (0.3-0.6 mg). Results are given as nmol/mg protein/h 
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These results demonstrate that the rabbit sciatic 
nerve, able to synthesize alkanes [5] can also synthe- 
size saturated very long chain fatty acids; the total 
elongating activity is somewhat comparable to that 
observed in the central nervous system. The biosyn- 
thesis occurs in the microsomal fraction, in the 
presence of stearoyl CoA, malonyl CoA and NADPH. 
From analytical and biochemical data [ 1-5 34-361 
we postulated recently a plausible relationship between 
very long chain acids and alkanes. These results are in 
good agreement with that proposal. 
Since alkanes can be considered as characteristic of 
a normal myelination, a possible approach of the 
myelin formation may be the study of the different 
steps - including fatty acids - involved in alkane bio- 
synthesis as well as a further investigation of their 
insertion in both normal and abnormal (mutant) 
myelin. That work is under progress in our laboratory. 
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